Ensysce Biosciences Receives Notice of Allowance for Patent Covering Opioid Families Using TAAP™ and MPAR® Technologies in Brazil.

Ensysce Biosciences has received a Notice of Allowance from the Brazilian Patent Office for a patent covering additional opioid families using its proprietary TAAP and MPAR technologies. This expands the company's global protection for next-generation analgesics and strengthens its intellectual property estate. The patent includes composition of matter and method of use claims, further reducing the potential for abuse and overdose. Ensysce's CEO states that this progress moves the company closer to a future in which patients can be treated effectively without the devastating consequences of misuse or overdose.